Linda Chang joins PharmAthene as CFO
This article was originally published in Scrip
Executive Summary
PharmAthene, a company developing and commercialising medical countermeasures against biological and chemical weapons, has appointed Linda Chang senior vice-president and chief financial officer. Prior to joining PharmAthene Ms Chang was senior director of finance at Human Genome Sciences.